Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063255 · ClinicalTrials.gov registry record · Phase 4
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade
A Phase 4 study of Cancer of Bladder, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03063255: Completed Phase 4 study of Cancer of Bladder, sponsored by University of Florida.
NCT03063255 is a Phase 4 study of Cancer of Bladder that has completed, run by University of Florida. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03063255, a Phase 4 study of Cancer of Bladder, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.
Primary Outcome
Nerve Integrity Monitor will be used to detect adductor spasm and below are listed the numbers or patients with increased incidence of adductor spasm.
Conditions Studied
Interventions
- DRUG Obturator block
- DRUG Neuromuscular block
Study Locations (1)
Florida
- Malcom Randall VA Medical Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2019-09-19 |
| Phase | Phase 4 |
What the finished NCT03063255 record still lists
NCT03063255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Cancer of Bladder appearing as the primary indexed condition, and to 2 interventions - of which Obturator block is the first listed.
NCT03063255 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03063255 about?
NCT03063255 is a clinical study titled "Comparison of Obturator Nerve Blockade and Neuromuscular Blockade". Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex durin...
What is the current status of trial NCT03063255?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2017-04-25. Estimated completion is 2019-09-19.
What conditions does trial NCT03063255 study?
This clinical trial studies the following conditions: Cancer of Bladder.
What interventions are being tested in trial NCT03063255?
The interventions under investigation include: Obturator block (DRUG), Neuromuscular block (DRUG).
Who is sponsoring clinical trial NCT03063255?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03063255 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03063255's enrollment target sits among peer trials
60 1125th of 2000 higher than 800 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI